Search

FDA letter sent to Edenbridge Pharmaceuticals demonstrates the challenges of getting pharma advertising right.

US Senator Elizabeth Warren calls for a federal investigation into GSK and its discontinuation of Flovent HFA

Why scientists are looking to the microscopic marvel of the tardigrade for new approaches to cancer treatment.

Celebrating the winner of our annual Innovation Awards: a service for co-crystal prediction.

How antisense oligonucleotides open up targeted approaches to rare disease treatment.

A new study reports targeted CRISPR delivery in retinal and neurological disease models – without viral vectors.

To shareholders – according to an analysis of financial reports from healthcare companies.

A Lassa fever vaccine candidate shows promise in animal studies, with guinea pigs 100 percent protected from lethal virus exposure.

A regulatory science push in the UK includes centres for digital transformation, AI and more.

The Access to Medicine Foundation has developed the 2026 AMR Benchmark to recognize and promote urgency in the ongoing AMR challenge.